Concepedia

Thanh-Trang T. Vo

TT

Statistics

Publications

5

Citations

744

H-Index

5

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Irvine

Dana-Farber Cancer Institute

Thanh-Trang T. Vo is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, hematologic malignancy therapy, and pharmacology.

ORCID

Publications per year

2011–2018

5

Publications

5

Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

Tríona Ní Chonghaile, Kristopher A. Sarosiek, Thanh-Trang T. Vo et al. · Science · 2011 · 587 citations

, , +17

Statins enhance efficacy of venetoclax in blood cancers

J. Scott Lee, Andrew W. Roberts, Dennis Juarez et al. · Science Translational Medicine · 2018 · 86 citations · Full text

, , +16

mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells

Brandon Beagle, Duc Nguyen, Sharmila Mallya et al. · Oncotarget · 2014 · 34 citations · Full text

, , +15

mTOR inhibition enhances efficacy of dasatinib in <i>ABL</i>-rearranged Ph-like B-ALL

Moran Gotesman, Thanh-Trang T. Vo, Lee-or Herzog et al. · Oncotarget · 2018 · 21 citations · Full text

, , +15

mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph+ and Ph-like B-ALL

Thanh-Trang T. Vo, J. Scott Lee, Duc Nguyen et al. · Molecular Cancer Therapeutics · 2017 · 16 citations · Full text

, , +17

1–5 of 5